CYCN · catalysts, narrative & risks

What is driving the CYCN signal (addressing the scout directly)

The most important thing to know about CYCN right now is that the company has effectively ceased to exist as CYCN. Per the official company release, Korsana Biosciences completed its merger with Cyclerion Therapeutics, and the combined company began trading on Nasdaq under the ticker "KRSA" on September 9, 2026 [3]. Former Cyclerion shares were converted (after a 1-for-7 reverse split of Cyclerion stock) into shares of the combined entity, which now carries a new CUSIP (23255M303) [3].